Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Pernix Therapeutics Holdings, Inc. (“Pernix”, the “Company, “we” or “our”) is a specialty pharmaceutical company focused on the sales, marketing, manufacturing and development of branded, generic and over-the-counter, which we refer to herein as OTC, pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas. We expect to execute our growth strategy which includes the horizontal integration of our branded prescription, generic and OTC businesses. We also plan to continue to make strategic acquisitions of products and companies, as well as develop and in-license additional products. We manage a portfolio of branded and generic products. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.03 |
| Quarterly EPS Est: | -0.14 |
| PEG Ratio: | -.35 |
|
Mean Recommendation: View Summary / View All |
1.6 |
Data is provided by Zacks Investment Research

